7 Recruiting AML Phase 2 Clinical Trials
Active phase 2 studies for aml enrolling across the USA. Verify eligibility and contact site coordinators.
All AML studiesPhase 2 Studies for AML
🔵 Active, Not Recruiting Phase1 / Phase2
ALLG AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial
📍 The University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
📍 University of Rochester — Rochester, New York
View Study & Checklist ➔ 🟢 Recruiting Phase2
Cardioprotection in AML
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
📍 Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔ 🟢 Recruiting Phase2
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML
📍 UT MD Anderson — Houston, Texas
View Study & Checklist ➔